Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV001264132 | SCV001442233 | likely pathogenic | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2020-03-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541614 | SCV003294695 | pathogenic | Qualitative or quantitative defects of dysferlin | 2022-01-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys1621*) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. ClinVar contains an entry for this variant (Variation ID: 984125). For these reasons, this variant has been classified as Pathogenic. |